Showcases Stock ranks Forex

Chembio Diagnostics (CEMI)
6.55  0.24 (3.8%) 01-25 16:00
Open: 6.25 Pre. Close: 6.31
High: 6.55 Low: 6.01
Volume: 905,234 Market Cap: 132M
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for HIV and Syphilis, and Zika virus. It also develops tests for malaria, Dengue virus, chikungunya virus, ebola, lassa, marburg, leptospirosis, Rickettsia typhi, Burkholderia pseudomallei, and Orientia tsutsugamushi. In addition, the company develops tests for a specific form of cancer, concussion, and bovine tuberculosis; and handheld optical analyzers for rapid diagnostic tests. It sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, or DPP trademarks, as well as under the private labels of its marketing partners to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. The company has collaboration agreements with Concussion Science Group Division of Perseus Science Group LLC to develop a POC diagnostic test for traumatic brain injury; Foundation for Innovative New Diagnostics to develop a POC fever panel assay for life-threatening acute febrile illnesses; AstraZeneca to develop a POC test for eosinophilic respiratory disease; and Shire Human Genetic Therapies, Inc. to develop a novel POC diagnostic test. It also has a strategic partnership with LumiraDx Limited to develop point-of-care diagnostic tests for the detection of the COVID-19 virus, and IgM and IgG antibodies on the LumiraDx and Chembio DPP platforms. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 6.559 - 6.585 6.585 - 6.61
Low: 5.948 - 5.976 5.976 - 6.002
Close: 6.503 - 6.549 6.549 - 6.593
Stock Technical Analysis
Target: Six months: 7.70
One year: 8.99
Support: Support1: 5.37
Support2: 4.62
Resistance: Resistance1: 6.59
Resistance2: 7.70
Pivot: 5.64
Moving Averages: MA(5): 6.23
MA(20): 5.45
MA(100): 5.05
MA(250): 5.95
MACD: MACD(12,26): 0.25
Signal(12,26,9): 0.11
%K %D: %K(14,3): 87.86
%D(3): 82.47
RSI: RSI(14): 66.23
52-Week: High: 15.89
Low: 2.25
Change(%): 64.2
Average Vol(K): 3-Month: 158269
10-Days: 124810
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.

CEMI has closed below upper band by 5.9%. Bollinger Bands are 35.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
Sun, 24 Jan 2021
Chembio Diagnostics - Consensus Indicates Potential 45.2% Upside - DirectorsTalk Interviews

Sat, 16 Jan 2021
Is Chembio Diagnostics, Inc.'s (NASDAQ:CEMI) Shareholder Ownership Skewed Towards Insiders? - Simply Wall St

Thu, 14 Jan 2021
BUZZ-U.S. STOCKS ON THE MOVE-China tech giants, NantKwest, Chembio Diagnostics, Delta Air Lines - Nasdaq

Thu, 14 Jan 2021
Premarket Mover: Chembio Diagnostics Inc (CEMI) Up 12.80% - InvestorsObserver

Thu, 14 Jan 2021
Chembio Diagnostics Announces CE Mark for DPP SARS-CoV-2 Antigen and IgM/IgG Test Systems - Yahoo Finance

Mon, 04 Jan 2021
Demand for Pandemic Testing Could Rise Substantially with New Strain of Virus -

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. (M) 20.18
Shares Float (M) 17.52
% Held by Insiders 13.89
% Held by Institutions 33.75
Shares Short (K) 3870
Shares Short Prior Month (K) 4140
Stock Financials
EPS -1.220
Book Value (p.s.) 1.680
Profit Margin -76.55
Operating Margin -63.26
Return on Assets (ttm) -18.1
Return on Equity (ttm) -74.6
Qtrly Rev. Growth 5.7
Gross Profit (p.s.) 0.175
Sales Per Share 1.442
EBITDA (p.s.) -0.811
Qtrly Earnings Growth
Operating Cash Flow (M) -16.80
Levered Free Cash Flow (M) -11.51
Stock Valuation
PE Ratio -5.37
PEG Ratio
Price to Book value 3.90
Price to Sales 4.54
Price to Cash Flow -7.87
Stock Dividends
Dividend Yield
Dividend Growth

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator